GT Biopharma Inc (GTBP)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 03-2021 | 12-2020 | 09-2020 | 06-2020 | 03-2020 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -29,677 | -28,296 | -22,006 | -19,130 | -1,708 |
| Depreciation Amortization | N/A | 317 | N/A | 1 | N/A |
| Accounts payable and accrued liabilities | N/A | -838 | 1,165 | N/A | N/A |
| Other Working Capital | 1,215 | 17,065 | 1,168 | 187 | 847 |
| Other Operating Activity | 24,778 | 4,490 | 14,338 | 15,308 | 638 |
| Operating Cash Flow | $-3,684 | $-7,262 | $-5,335 | $-3,634 | $-223 |
| Cash Flows From Investing Activities | |||||
| Investing Cash Flow | $N/A | $N/A | $N/A | $N/A | $N/A |
| Cash Flows From Financing Activities | |||||
| Debt Issued | 1,205 | 12,531 | 5,657 | 4,457 | 200 |
| Common Stock Issued | 24,737 | N/A | 0 | 0 | N/A |
| Financing Cash Flow | $25,942 | $12,531 | $5,657 | $4,457 | $200 |
| Beginning Cash Position | 5,297 | 28 | 28 | 28 | 28 |
| End Cash Position | 27,555 | 5,297 | 350 | 851 | 5 |
| Net Cash Flow | $22,258 | $5,269 | $322 | $823 | $-23 |
| Free Cash Flow | |||||
| Operating Cash Flow | -3,684 | -7,262 | -5,335 | -3,634 | -223 |
| Free Cash Flow | -3,684 | -7,262 | -5,335 | -3,634 | -223 |